Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003503071 | SCV004318224 | pathogenic | Glycogen storage disease, type II | 2023-08-25 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the GAA protein in which other variant(s) (p.Leu552Pro) have been determined to be pathogenic (PMID: 14695532, 17616415, 18607768, 19588081, 20638881). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with GAA-related conditions. This variant is not present in population databases (gnomAD no frequency). This variant, c.1651_1656del, results in the deletion of 2 amino acid(s) of the GAA protein (p.Thr551_Leu552del), but otherwise preserves the integrity of the reading frame. |